The FDA said they recommended an RCT, either in kids or adults.
A successful trial in adults likely would've added weight to the application for approval for kids.
MSB didn't do it.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$2.41 |
Change
0.060(2.55%) |
Mkt cap ! $3.084B | |||
| Open | High | Low | Value | Volume |
| $2.41 | $2.49 | $2.40 | $25.69M | 10.57M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 32500 | $2.40 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.42 | 50000 | 1 |
View Market Depth
| Last trade - 16.10pm 19/09/2025 (20 minute delay) ? |
| MSB (ASX) Chart |